KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gilead Sciences (GILD) FCF Payout Ratio (2016 - 2026)

Gilead Sciences filings provide 12 years of FCF Payout Ratio readings, the most recent being 0.31 for Q4 2025.

  • On a quarterly basis, FCF Payout Ratio fell 9.69% to 0.31 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.42, a 10.31% increase, with the full-year FY2025 number at 0.42, up 10.95% from a year prior.
  • FCF Payout Ratio hit 0.31 in Q4 2025 for Gilead Sciences, up from 0.25 in the prior quarter.
  • In the past five years, FCF Payout Ratio ranged from a high of 1.38 in Q2 2025 to a low of 0.23 in Q3 2024.
  • Median FCF Payout Ratio over the past 5 years was 0.42 (2023), compared with a mean of 0.49.
  • The widest YoY moves for FCF Payout Ratio: up 88.65% in 2024, down 59.83% in 2024.
  • Gilead Sciences' FCF Payout Ratio stood at 0.3 in 2021, then rose by 29.34% to 0.38 in 2022, then increased by 26.78% to 0.49 in 2023, then dropped by 28.51% to 0.35 in 2024, then decreased by 9.69% to 0.31 in 2025.
  • The last three reported values for FCF Payout Ratio were 0.31 (Q4 2025), 0.25 (Q3 2025), and 1.38 (Q2 2025) per Business Quant data.